Pradaxa News and Information

Pradaxa Lawsuits Update: Boehringer to Pay $931,000 Fine Over Lost Pradaxa Files

Pradaxa Lawsuits

Pradaxa LawsuitsA judge has ruled that German pharmaceutical company, Boehringer Ingelheim, must pay a $931,000 fine after the drug maker allegedly failed to preserve or withheld files sought by patients currently filing Pradaxa lawsuits against the company. The judge, in charge of over1,700 consolidated Pradaxa lawsuits, concluded that company executives acted in bad faith by failing to preserve files and documents about Pradaxa’s development.

If you or a loved one took Pradaxa and you suffered from excessive bleeding, blood clots or other complications, Pradaxa lawsuits can help you to recover damages for your condition. Contact the American Injury Attorney Group to learn more about your legal rights.

Boehringer to Pay Fine in Pradaxa Lawsuits

Judge David Herndon ruled on December 9, 2013 that the inadequacy of Boehringer Ingelheim’s efforts to safeguard the documents justified a fine of nearly $1 million against the company. The manufacturer is preparing to face the first federal court trial in which plaintiffs claim that the drug maker hid the risks of bleeding while taking Pradaxa. The first consolidated case is scheduled to begin in August. State courts in Connecticut, California, Illinois and Delaware will also see Pradaxa trials.

Judge Herndon ruled that company officials failed to take obvious steps to preserve files and made misrepresentations about their efforts to preserve documents. Executives also failed to ensure the auto-delete feature of the company’s cellular telephones was turned off so that text messages could be preserved.

However, Boehringer Ingelheim asserts that these problems have not inhibited plaintiffs from finding other documents pertaining to Pradaxa, including the safety, regulatory and central science documents regarding the drug. Still, patients say that the drug maker should have required its employees to preserve documents about the company’s marketing plan and about the drug’s development. The company is unable to produce documents by consultants who worked on the marketing plan or the files of a high-level scientist involved in developing Pradaxa, according to pending Pradaxa lawsuits.

On the other hand, Boehringer has acknowledged that it has released 32 million pages of material to plaintiffs regarding Pradaxa. Additionally, Boehringer claims that several document requests made by plaintiffs are not relevant to the Pradaxa lawsuits.

Patients and other plaintiffs also allege that the company knew that the drug posed a deadly risk to consumers when the medication was introduced to the U.S. in October 2010. However, unlike older blood thinners, Pradaxa was not released with an antidote to reverse its effects and can thus result in “bleed-out” deaths.

Pending Pradaxa Lawsuits

Pradaxa was first introduced in 2010 as a means to prevent strokes in patients with atrial fibrillation. The drug has recently been used to prevent deep vein thrombosis and pulmonary embolisms in patients requiring hip or knee replacement procedures. However, clinical trials have concluded that Pradaxa may increase the patient’s risk of blood clots, and many across the U.S. are filing Pradaxa lawsuits after allegedly suffering from life-threatening health complications.

According to records, Pradaxa has brought in over $1 billion in sales across the globe for the drug maker, and researchers have found it to be more effective at preventing strokes than other blood thinners. Still, plaintiffs allege that Boehringer Ingelheim marketed Pradaxa as superior when it was known that Pradaxa’s performance was not necessarily better than alternative medications.

Although Pradaxa was approved in 2010 by the U.S. Food and Drug Administration (FDA) as an effective and safe alternative to Coumadin, concerns about the safety of the medication surfaced after physicians began to prescribe the medication. In 2011, FDA officials acknowledged receipt of 3,781 incidents of side effects and 542 reports of deaths in patients taking the medication.

Need More Information about Pradaxa Lawsuits? Contact Us Today

If you or a loved one have suffered from blood clots, strokes or other complications while taking Pradaxa, you may wish to join the growing number of plaintiffs who are filing Pradaxa lawsuits and seeking compensation for their injuries. Contact the American Injury Attorney Group today for your free, no-obligation consultation to determine if you have a valid claim. We will connect you with an affiliated, knowledgeable attorney who understands the claims in the pending Pradaxa lawsuits and who will work to help you seek the compensation to which you may be entitled.

 

FREE Case Evaluation

Share Your Thoughts!

Please note that you are not considered a client until your case has been accepted by the law firm of Johnson & Vines, PLLC and you have signed a contract for legal services with that law firm. Prior results do not guarantee or predict a similar outcome with respect to any future matter. The information contained on this website is neither medical nor legal advice and is not intended to be medical or legal advice. Nor is it a substitute for seeking other appropriate professional advice. Please discuss any health or other concerns with your doctor or other healthcare professional. No recommendation or endorsement of AIAG is implied by reference to any newspaper or television or radio station. This website may constitute “Attorney Advertising” under the Arkansas Rules of Professional Conduct and under the law of other jurisdictions. Your use of our website constitutes your acceptance of the Terms of Use, Privacy Policy and other terms and conditions set forth on our DISCLAIMERS PAGE. © 2013 American Injury Attorney Group. All rights reserved. Principal law office address for Johnson & Vines, PLLC: 2226 Cottondale Ln., Suite 200, Little Rock, Arkansas 72202.

Copyright ©2014. All Rights Reserved.